Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ballantyne

Showing results (451-460 of 999) with videos related to

Pageof 100
Sort By:
Circulation|September 24, 2024
NT-proBNP and Cardiac Troponin I, but Not Cardiac Troponin T, Are Associated With 7-Year Changes in Cardiac Structure and Function in Older Adults: The ARIC StudyPeder L Myhre, Brian Claggett, Christie M Ballantyne, et al.
Diabetes, Obesity & Metabolism|August 4, 2004
Characteristics of US adults with the metabolic syndrome and therapeutic implicationsT A Jacobson, C C Case, S Roberts, et al.
The American Journal of Cardiology|April 28, 2022
Long-Term Safety and Efficacy of Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from the CLEAR Harmony Open-Label Extension Study)Christie M Ballantyne, Maciej Banach, Harold E Bays, et al.
Diabetologia|March 11, 2022
Diabetes, GDF-15 and incident heart failure: the atherosclerosis risk in communities studyJustin B Echouffo-Tcheugui, Natalie Daya, Chiadi E Ndumele, et al.
The American Journal of Cardiology|February 7, 2009
Efficacy and safety of ABT-335 (fenofibric acid) in combination with atorvastatin in patients with mixed dyslipidemiaAnne C Goldberg, Harold E Bays, Christie M Ballantyne, et al.
International Journal of Cardiology|April 17, 2015
Patterns and determinants of temporal change in high-sensitivity cardiac troponin-T: The Atherosclerosis Risk in Communities Cohort StudyJohn W McEvoy, Mariana Lazo, Yuan Chen, et al.
Archives of Internal Medicine|March 8, 2003
Risk for myopathy with statin therapy in high-risk patientsChristie M Ballantyne, Alberto Corsini, Michael H Davidson, et al.
Atherosclerosis|February 22, 2012
The 9p21 genetic variant is additive to carotid intima media thickness and plaque in improving coronary heart disease risk prediction in white participants of the Atherosclerosis Risk in Communities (ARIC) StudyVijay Nambi, Eric Boerwinkle, Kim Lawson, et al.
Circulation|June 1, 1994
Molecular evidence for induction of intracellular adhesion molecule-1 in the viable border zone associated with ischemia-reperfusion injury of the dog heartK A Youker, H K Hawkins, G L Kukielka, et al.
Journal of Clinical Lipidology|January 29, 2013
A novel mutation in the ABCA1 gene causing an atypical phenotype of Tangier diseaseSmita I Negi, Ariel Brautbar, Salim S Virani, et al.
Pageof 100

Showing results (451-460 of 999) with videos related to

Sort By:
Pageof 100
Circulation|September 24, 2024
NT-proBNP and Cardiac Troponin I, but Not Cardiac Troponin T, Are Associated With 7-Year Changes in Cardiac Structure and Function in Older Adults: The ARIC StudyPeder L Myhre, Brian Claggett, Christie M Ballantyne, et al.
Diabetes, Obesity & Metabolism|August 4, 2004
Characteristics of US adults with the metabolic syndrome and therapeutic implicationsT A Jacobson, C C Case, S Roberts, et al.
The American Journal of Cardiology|April 28, 2022
Long-Term Safety and Efficacy of Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from the CLEAR Harmony Open-Label Extension Study)Christie M Ballantyne, Maciej Banach, Harold E Bays, et al.
Diabetologia|March 11, 2022
Diabetes, GDF-15 and incident heart failure: the atherosclerosis risk in communities studyJustin B Echouffo-Tcheugui, Natalie Daya, Chiadi E Ndumele, et al.
The American Journal of Cardiology|February 7, 2009
Efficacy and safety of ABT-335 (fenofibric acid) in combination with atorvastatin in patients with mixed dyslipidemiaAnne C Goldberg, Harold E Bays, Christie M Ballantyne, et al.
International Journal of Cardiology|April 17, 2015
Patterns and determinants of temporal change in high-sensitivity cardiac troponin-T: The Atherosclerosis Risk in Communities Cohort StudyJohn W McEvoy, Mariana Lazo, Yuan Chen, et al.
Archives of Internal Medicine|March 8, 2003
Risk for myopathy with statin therapy in high-risk patientsChristie M Ballantyne, Alberto Corsini, Michael H Davidson, et al.
Atherosclerosis|February 22, 2012
The 9p21 genetic variant is additive to carotid intima media thickness and plaque in improving coronary heart disease risk prediction in white participants of the Atherosclerosis Risk in Communities (ARIC) StudyVijay Nambi, Eric Boerwinkle, Kim Lawson, et al.
Circulation|June 1, 1994
Molecular evidence for induction of intracellular adhesion molecule-1 in the viable border zone associated with ischemia-reperfusion injury of the dog heartK A Youker, H K Hawkins, G L Kukielka, et al.
Journal of Clinical Lipidology|January 29, 2013
A novel mutation in the ABCA1 gene causing an atypical phenotype of Tangier diseaseSmita I Negi, Ariel Brautbar, Salim S Virani, et al.
Pageof 100